<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00389558</url>
  </required_header>
  <id_info>
    <org_study_id>MRAP190406</org_study_id>
    <nct_id>NCT00389558</nct_id>
  </id_info>
  <brief_title>Antiseptic Use and Dressing Application</brief_title>
  <official_title>Comparison of Amukin Versus Biseptine Use for Dressing Application of Epicutaneocavous Catheters for Nosocomial Infection Prevention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maternite Regionale Universitaire</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maternite Regionale Universitaire</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of the study are:

        1. To compare the local efficacy (skin colonization) of 2 commercialized antiseptics used
           for the disinfection of the dressing application for an epicutaneocavous catheter (EPI).

        2. To evaluate whether the bacteria responsible for nosocomial infection is comparable to
           the flora diagnosed at the EPI site.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epicutaneocavous catheter is a significant risk factor for nosocomial infection in newborn
      infants. These infections have been related to local bacterial colonisation. Therefore
      thorough disinfection should lower the risk of nosocomial infection. However, the local
      efficacy of antiseptic use has not yet been clearly evaluated in this situation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy on skin colonization of two commercially available antiseptics</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>In case of nosocomial infection, relationship with skin bacteria</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">453</enrollment>
  <condition>Skin Colonization</condition>
  <condition>Catheterization</condition>
  <condition>Bacterial Infection</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Biseptine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Amukin</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>disinfection efficacy using Biseptine</intervention_name>
    <description>Detersion and antiseptic application when changing catheter dressing</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Biseptine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>disinfection efficacy using Amukin</intervention_name>
    <description>Detersion and antiseptic application when changing catheter dressing</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Amukin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All infants admitted to the Neonatal Intensive Care Unit

          -  Epicutaneocavous catheter insertion indication

        Exclusion Criteria:

          -  Epicutaneocavous catheter not inserted within the Unit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Michel HASCOET, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of NANCY, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Monique LUX, Pharmacist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maternite Regionale Universitaire</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maternite Regionale Universitaire</name>
      <address>
        <city>Nancy</city>
        <zip>54042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.maternite.chu-nancy.fr</url>
    <description>(home page of the hospital)</description>
  </link>
  <reference>
    <citation>Mahieu LM, De Dooy JJ, De Muynck AO, Van Melckebeke G, Ieven MM, Van Reempts PJ. Microbiology and risk factors for catheter exit-site and -hub colonization in neonatal intensive care unit patients. Infect Control Hosp Epidemiol. 2001 Jun;22(6):357-62.</citation>
    <PMID>11519913</PMID>
  </reference>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2006</study_first_submitted>
  <study_first_submitted_qc>October 17, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2006</study_first_posted>
  <last_update_submitted>September 18, 2009</last_update_submitted>
  <last_update_submitted_qc>September 18, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof JM HASCOET</name_title>
    <organization>Maternite Regionale Universitaire</organization>
  </responsible_party>
  <keyword>Skin colonization</keyword>
  <keyword>Antiseptic</keyword>
  <keyword>Epicutaneocavous catheter dressing</keyword>
  <keyword>Infant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents, Local</mesh_term>
    <mesh_term>Amikacin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

